Related references
Note: Only part of the references are listed.Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data
Alice Boileve et al.
EUROPEAN JOURNAL OF CANCER (2023)
Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
Freba Grawe et al.
CANCER IMAGING (2023)
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
Isabella Reccia et al.
CANCERS (2023)
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
David L. Chan et al.
BRITISH JOURNAL OF CANCER (2023)
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Mina M. Swiha et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature
Anne-Leen Deleu et al.
EJNMMI RESEARCH (2022)
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
Vittoria Rufini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Clinical and Prognostic Value of PET/CT Imaging with Combination of Ga-68-DOTATATE and F-18-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
Panpan Zhang et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
Lisa Bodei et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
David L. H. Chan et al.
THERANOSTICS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Principles of diagnosis and management of neuroendocrine tumours
Michael J. Raphael et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)
The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
Evangelia Skoura et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
Bernhard Nilica et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors
Mattias Sandstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Role of PET/CT in the functional imaging of endocrine pancreatic tumors
Vittoria Rufini et al.
ABDOMINAL IMAGING (2012)
Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
Levent Kabasakal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Neuroendocrine Tumors Clinical Practice Guidelines in Oncology
Matthew H. Kulke et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours
Daniel Kaemmerer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Thorsten D. Poeppel et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
F Panzuto et al.
ENDOCRINE-RELATED CANCER (2005)